Use of methadone

Western Journal of Medicine

Volumn 172, Issue 1, 2000, Pages 43-46

  Anderson, Ilene B ^a   Kearney, Thomas E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; NARCOTIC AGENT; NARCOTIC ANALGESIC AGENT;

ARTICLE; DRUG INTERACTION; FEMALE; HUMAN; NEWBORN; OPIATE ADDICTION; PAIN; PREGNANCY; PREGNANCY COMPLICATION; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; DRUG INTERACTIONS; FEMALE; HUMANS; INFANT, NEWBORN; METHADONE; NARCOTICS; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; PAIN; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 0033630912     PISSN: 00930415     EISSN: None     Source Type: Journal    
DOI: 10.1136/ewjm.172.1.43     Document Type: Article

References (39)

1. Goldstein A, Herrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up. Drug Alcohol Depend 1995;40:139-150.
2. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 9th ed. New York (NY): McGraw-Hill Book Company; 1996:544-545.
3. Beaumont A, Hughes J. Biology of opioid peptides. Annu Rev Pharmacol Toxicol 1979;19:245-267.
4. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior, and criminality: a meta-analysis. Addiction 1998;93:515-532.
5. Metzger DS, Woody GE, McLellan AT, O'Brien CP, Druley P, Navaline H, et al. Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up. J Acquir Immune Defic Syndr 1993;6:1049-1056.
6. Bell J, Mattick R, Hay A, Chan J, Hall W. Methadone maintenance and drug-related crime. J Subst Abuse 1997;9:15-25.
7. Catalano RF, Gainey RR, Fleming CB, Haggerty KP, Johnson NO. An experimental intervention with families of substance abusers: one-year follow-up of the focus on families project. Addiction 1999;94:241-254.
8. Caplehorn JR, Dalton MS, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance in addicts' risk of fatal heroin overdose. Subst Use Misuse 1996;31:177-196.
9. McEvoy GK, Welsh OH, Snow EK, eds. American Hospital Formulary Service Drug Information. Bethesda (Md): American Society of Health-System Pharmacists; 1999.
10. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 1999;281:1000-1005.
11. Caplehorn JR, Bell J, Kleinbaum DG, Gebski VJ. Methadone dose and heroin use during maintenance treatment. Addiction 1993;88:119-124.
12. Unnithan S, Gossop M, Strang J. Factors associated with relapse among opiate addicts in an out-patient detoxification programme. Br J Psychiatry 1992;161:654-657.
13. Dole V. Implications of methadone maintenance for theories of narcotic addiction. JAMA 1988;260:3025-3029.
14. Wesson DR, Gay GR, Smith DE. Treatment techniques for narcotic withdrawal with special reference to mixed narcotic-sedative addictions. J Psychedelic Drugs 1971;4:118-122.
15. Sawe J, Hansen J, Ginman C, Hartvig P, Jakobsson PA, Nilsson MI, et al. Patient-controlled dose regimen of methadone for chronic cancer pain. Br Med J (Clin Res Ed) 1981;282:771-773.
16. Beaver WT, Wallenstein SL, Houde RW, Rogers A. A clinical comparison of the analgesic effects of methadone and morphine administered intramuscularly, and of orally and parenterally administered methadone. Clin Pharmacol Ther 1967;8:415-426.
17. Ripamonti C, Groff L, Brunelli C, Polastri D, Stavrakis A, De Conno F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol 1998;16:3216-3221.
18. Verebely K, Volavka J, Mule S, Resnick R. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment. Clin Pharmacol Ther 1975;18:180-190.
19. Rajegowda BK, Glass L, Evans HE, Maso G, Swartz DP, Leblanc W. Methadone withdrawal in newborn infants. J Pediatr 1972;81:532-534.
20. Zuspan FP, Gumpel JA, Mejia-Zelaya A, et al. Fetal stress from methadone withdrawal. Am J Obstet Gynecol 1975;122:43-46.
21. Kandall SR, Doberczak TM, Jantunen M, et. al. The methadone-maintained pregnancy, Clin Perinatol 1999; Mar 26:173-183.
22. Doberczak TM, Thornton JC, Bernstein J, Madden J, Davis R. Impact of maternal drug dependency on birth weight and head circumference of offspring. Am J Dis Child' 1987;141:1163-1167.
23. Pond SM, Kreek MJ, Tong TG, Taghunath J, Benowitz NL. Altered methadone pharmacokinetics in methadone-maintained pregnant women. J Pharmacol Exp Ther 1985;233:1-6.
24. Zweben JE, Payte JT. Methadone maintenance in the treatment of opioid dependence: a current perspective. West J Med 1990;152:588-599.
25. Maurer P, Bartkowski R. Drug interactions of clinical significance with opioid analgesics. Drug Safety 1993;8:30-48.
26. Tong TG, Pond SM, Kreek MJ, Jaffery NF, Benowitz NL. Phenytoin-induced methadone withdrawal. Ann Intern Med 1981;94:349-351.
27. Heelon MW, Meade LB. Methadone withdrawal when starting an antiretroviral regimen including nevirapine. Pharmacotherapy 1999;19:471-472.
28. Hsu A, Granneman GR, Bertz RJ. Ritonavir: clinical pharmacokinetics and interactions with other anti-HIV agents [erratum published in Clin Pharmacokinet 1998;35:473]. Clin Pharmacokinet 1998;35:275-291.
29. Alderman CP, Frith PA. Fluvoxamine-methadone interaction. Aust N Z J Psychiatry 1999;33:99-101.
30. McCance-Katz EF, Rainey PM, Jatlow P, Friedland G. Methadone effects on zidovudine disposition (AIDS Clinical Trials Group 262). J Acquir Immune Defic Syndr Hum Retrovirol 1998;18:435-443.
31. Maany I, Dhopesh V, Arndt IO, Burke W, Woody G, O'Brien CP. Increase in desipramine serum levels associated with methadone treatment. Am J Psychiatry 1989;146:1611-1613.
32. Barrett DH, Luk AJ, Parrish RG, Jones TS. An investigation of medical examiner cases in which methadone use was detected, Harris County, Texas, 1987-1992. J Forensic Sci 1996;41:442-448.
33. Harding-Pink D. Opioid toxicity - methadone: one person's maintenance dose is another's poison [Letter]. Lancet 1993;341:665-666.
34. Norris JV, Don HF. Prolonged depression of respiratory rate following methadone analgesia. Anesthesiology 1976;45:361-362.
35. Drummer OH, Syrjanen M, Opeskin K, Cordner S. Deaths of heroin addicts starting on a methadone maintenance programme [Letter]. Lancet 1990;335:108.
36. Presant S, Knight L, Klassen G. Methadone-induced pulmonary edema. Can Med Asoc J 1975;113:966-967.
37. Yaffe G, Strelinger R, Partwatikar S. Physical symptom complaints of patients on methadone maintenance. In: The Fifth National Conference on Methadone Treatment, vol 2. New York (NY): National Association for the Prevention of Addiction to Narcotics; 1973:507-514.
38. Kreek M. Medical complications in methadone patients. Ann N Y Acad Sci 1978;311:110-134.
39. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective medical treatment of opiate addiction. JAMA 1998;280:1936-1943.